Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin.

scientific article published on 4 September 2009

Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00259-009-1260-4
P698PubMed publication ID19760414

P50authorUmberto VeronesiQ780378
Viviana GalimbertiQ33275494
Giovanni PaganelliQ43039252
Rita De SantisQ56441584
Giuseppina A Di DiaQ84390417
Roberto OrecchiaQ105532303
P2093author name stringAlberto Luini
Concetta De Cicco
Marta Cremonesi
Stefano Zurrida
Gianmatteo Pagani
Giuseppe Carbone
Maria Cristina Leonardi
Annamaria Ferrari
Monica Pacifici
Mahila E Ferrari
P2860cites workEffects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsQ29031162
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyQ29615701
Estimates of radiation-absorbed dose to kidneys in patients treated with 90Y-ibritumomab tiuxetanQ34117144
Accelerated treatment of breast cancerQ34205264
Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancerQ34689002
Standard for breast conservation therapy in the management of invasive breast carcinomaQ34938061
Does delay in starting treatment affect the outcomes of radiotherapy? A systematic reviewQ35057465
TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiationQ36089129
Conservative treatment of breast cancer: its evolution.Q36301200
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy.Q36354606
Dosimetry in Peptide radionuclide receptor therapy: a review.Q36586256
MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.Q40035683
Treatment of local breast carcinoma in Florida: the role of the distance to radiation therapy facilitiesQ40369648
Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trialsQ43465146
Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic resultsQ43686600
Adequate locoregional treatment for early breast cancer may prevent secondary disseminationQ44373547
Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomideQ45119704
Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationshipQ45226554
Natural antibodies to avidin in human serumQ46227206
The impact of radiation on early breast carcinoma survival. A Bayesian analysis.Q50615497
Biologic comparison of partial breast irradiation protocols.Q51982632
The effect of delay in treatment on local control by radiotherapy.Q52314322
Detection of prosthetic vascular graft infection using avidin/indium-111-biotin scintigraphyQ70845146
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)Q72149116
Antibodies against biotinylated proteins are present in normal human serumQ72304086
Biodistribution in tumour-bearing mice of two 90Y-labelled biotins using three-step tumour targetingQ73169052
Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgeryQ73402074
Avidin targeting of intraperitoneal tumor xenograftsQ74038702
Clinical validation of the avidin/indium-111 biotin approach for imaging infection/inflammation in orthopaedic patientsQ77885236
Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancerQ78410812
IART: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiationQ79437754
The radiobiology of conventional radiotherapy and its application to radionuclide therapyQ81546873
OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicineQ81816056
Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 casesQ81880890
P433issue2
P1104number of pages9
P304page(s)203-211
P577publication date2009-09-04
P1433published inEuropean Journal of Nuclear Medicine and Molecular ImagingQ15708890
P1476titleIntraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin
P478volume37

Reverse relations

cites work (P2860)
Q847900913D dosimetry in patients with early breast cancer undergoing Intraoperative Avidination for Radionuclide Therapy (IART) combined with external beam radiation therapy
Q38967404AvidinOX-anchored biotinylated trastuzumab and pertuzumab induce down-modulation of ErbB2 and tumor cell death at concentrations order of magnitude lower than not-anchored antibodies.
Q30384834Biochemical and biological characterization of a new oxidized avidin with enhanced tissue binding properties.
Q90455060Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapy
Q47403446Design and solid phase synthesis of new DOTA conjugated (+)-biotin dimers planned to develop molecular weight-tuned avidin oligomers
Q39424591Development of sentinel node biopsy, ROLL and IART in early breast cancer at the European Institute of Oncology, Milan (IEO).
Q38383207Intraoperative radiotherapy in early breast cancer
Q44102830Investigation of 90Y-avidin for prostate cancer brachytherapy: a dosimetric model for a phase I-II clinical study.
Q64245291Lectin-Mediated pH-Sensitive Doxorubicin Prodrug for Pre-Targeted Chemotherapy of Colorectal Cancer with Enhanced Efficacy and Reduced Side Effects
Q35249333Post-lumpectomy intracavitary retention and lymph node targeting of (⁹⁹m)Tc-encapsulated liposomes in nude rats with breast cancer xenograft
Q39572340Preclinical pharmacology and safety of a novel avidin derivative for tissue-targeted delivery of radiolabelled biotin
Q42477444Therapeutic Use of Avidin Is Not Hampered by Antiavidin Antibodies in Humans
Q84994601Therapeutic nuclear medicine expands to breast cancer
Q39084057Triazole biotin: a tight-binding biotinidase-resistant conjugate